The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
U that was being developed by editas medicine and uh in the way this disease uh is sort of uh um sort of developed is that there is a mutation that causes degeneration uh in the eye and the idea is to use C9 uh use the same viral Vector system to deliver into the eye and have C9 inactivate this uh this mutant Gene so that it can uh slow down or stop degeneration
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
for example um LCA 10 is one of the ey diseases that uh there's already been a clinic uh crisper uh uh strategy being developed for